Ticker League

Regeneron Pharmaceuticals (REGN) Cash Flow Waterfall

Trace Regeneron Pharmaceuticals's operating cash flow down to free cash flow, then see where FCF goes — capex, buybacks, dividends, and debt repayment.

TTM

Operating CF

$5.01B

Capex

-$858M

Free Cash Flow

$4.16B

FCF Margin

+82.9%

Cash flow waterfall for Regeneron Pharmaceuticals (REGN) — TTM through Q1 2026

Free cash flow: $4.16B

Cash flow breakdown for Regeneron Pharmaceuticals (REGN) — TTM through Q1 2026

  • Operating Cash Flow$5.01B
  • Capital Expenditure-$858M
  • Free Cash Flow$4.16B
  • Other Investing-$848M
  • Share Buybacks-$3.19B
  • Dividends Paid-$374M
  • Other Financing & FX$136M
  • Net Cash Decrease-$122M
Want to see what drove the FCF change?Free Cash Flow Bridge

Frequently asked questions

Data & methodology